MW
Mark A Weinberger (Director) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in Johnson & Johnson (JNJ). Across 1 priced purchase filing, the average 21-session return was -1.7% from execution and -1.7% from disclosure (delay-adjusted; derived). The largest single filing was $147K of JNJ (1,000 sh × $147.22, as filed), executed Dec 12 2024. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-1.7%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-1.7%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
0d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$147K
shares × price, as filed
Last traded
Dec 12 2024
Filed Dec 12 2024
Median ADV $2.2B across their filed names
Open performance→Volume by month
Buys $147K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
JNJ
Johnson & Johnson
JNJ · 1 buy · 0 sells
1 filing
Recent filings
JNJPURCHASE
Johnson & Johnson
View filing →
$147K1,000 sh × $147.22
Exec Dec 12 2024
Filed Dec 12 2024 · 5:30 PM ET